Display options
Cite
Bogdanova NV, Schürmann P, Valova Y, et al. A Splice Site Variant of . Front Oncol. 2019;9:493doi: 10.3389/fonc.2019.00493.
Bogdanova, N. V., Schürmann, P., Valova, Y., Dubrowinskaja, N., Turmanov, N., Yugay, T., Essimsiitova, Z., Mingazheva, E., Prokofyeva, D., Bermisheva, M., Khusnutdinova, E., & Dörk, T. (2019). A Splice Site Variant of . Frontiers in oncology, 9493. https://doi.org/10.3389/fonc.2019.00493
Bogdanova, Natalia V, et al. "A Splice Site Variant of ." Frontiers in oncology vol. 9 (2019): 493. doi: https://doi.org/10.3389/fonc.2019.00493
Bogdanova NV, Schürmann P, Valova Y, Dubrowinskaja N, Turmanov N, Yugay T, Essimsiitova Z, Mingazheva E, Prokofyeva D, Bermisheva M, Khusnutdinova E, Dörk T. A Splice Site Variant of . Front Oncol. 2019 Jun 14;9:493. doi: 10.3389/fonc.2019.00493. eCollection 2019. PMID: 31259151; PMCID: PMC6587039.
Copy Download .nbib Format: NLM
Share it on

Front Oncol. 2019 Jun 14;9:493. doi: 10.3389/fonc.2019.00493. eCollection 2019.

A Splice Site Variant of .

Frontiers in oncology

Natalia V Bogdanova, Peter Schürmann, Yana Valova, Natalia Dubrowinskaja, Nurzhan Turmanov, Tatyana Yugay, Zura Essimsiitova, Elvira Mingazheva, Darya Prokofyeva, Marina Bermisheva, Elza Khusnutdinova, Thilo Dörk

Affiliations

  1. Gynaecology Research Unit, Hannover Medical School, Hanover, Germany.
  2. Radiation Oncology Research Unit, Hannover Medical School, Hanover, Germany.
  3. Department of Genetics and Fundamental Medicine, Bashkir State University, Ufa, Russia.
  4. Department of Clinical Immunology, Hannover Medical School, Hanover, Germany.
  5. Oncology Clinic of Almaty, Almaty, Kazakhstan.
  6. Department of Biology and Biotechnology, Kazakh State National University of Al-Farabi, Almaty, Kazakhstan.
  7. Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia.

PMID: 31259151 PMCID: PMC6587039 DOI: 10.3389/fonc.2019.00493

Abstract

CDK12 is a member of the cyclin-dependent kinase family that acts as regulator of DNA damage response gene expression. A c.1047-2A>G splice site variant of the

Keywords: DNA double-strand break repair; breast carcinoma; chromosome breakage syndrome; founder mutation; genetic susceptibility

References

  1. Hum Mutat. 2004 Jan;23(1):67-76 - PubMed
  2. Nat Genet. 2004 Dec;36(12):1255-7 - PubMed
  3. Breast Cancer Res Treat. 2009 Nov;118(1):207-11 - PubMed
  4. PLoS Genet. 2010 Oct 07;6(10):null - PubMed
  5. PLoS Biol. 2012 Jan;10(1):e1001229 - PubMed
  6. Clin Genet. 2012 Jul;82(1):100-1 - PubMed
  7. Breast Cancer Res Treat. 2013 Jan;137(2):533-9 - PubMed
  8. J Biol Chem. 2014 Mar 28;289(13):9247-53 - PubMed
  9. Genome Biol. 2014;15(6):122 - PubMed
  10. Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):15172-7 - PubMed
  11. N Engl J Med. 2015 Jun 4;372(23):2243-57 - PubMed
  12. Cancer Res. 2016 Apr 1;76(7):1882-91 - PubMed
  13. Adv Exp Med Biol. 2016;882:1-32 - PubMed
  14. Proc Natl Acad Sci U S A. 2016 Apr 26;113(17):E2373-82 - PubMed
  15. Cancer Treat Rev. 2016 Nov;50:83-88 - PubMed
  16. Cell Rep. 2016 Nov 22;17(9):2367-2381 - PubMed
  17. Nature. 2017 Nov 2;551(7678):92-94 - PubMed
  18. Int J Cancer. 2018 Jun 15;142(12):2512-2517 - PubMed
  19. Cancer Epidemiol Biomarkers Prev. 2018 Apr;27(4):380-394 - PubMed
  20. Cell. 2018 Jul 12;174(2):433-447.e19 - PubMed
  21. Front Oncol. 2018 Jun 14;8:227 - PubMed
  22. Cancer Cell. 2018 Aug 13;34(2):197-210.e5 - PubMed
  23. Cell. 2018 Jul 26;174(3):758-769.e9 - PubMed
  24. J Natl Cancer Inst. 2018 Aug 7;:null - PubMed
  25. Front Oncol. 2018 Aug 08;8:303 - PubMed
  26. N Engl J Med. 2018 Sep 13;379(11):1087-1089 - PubMed
  27. Front Oncol. 2018 Oct 02;8:421 - PubMed
  28. Nature. 2018 Dec;564(7734):141-145 - PubMed

Publication Types